Consolidated Statements of Stockholders’ Deficit - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income
Balance (in shares) at Oct. 31, 2022		979,869
Balance at the beginning of period at Oct. 31, 2022	$ (3,025)	$ 10	$ 1,172	$ (4,492)	$ 285
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	3,263			3,263
Other comprehensive loss, net of taxes	(508)				(508)
Comprehensive income	2,755
Issuance of common stock in connection with employee stock plans and other (in shares)		12,537
Issuance of common stock in connection with employee stock plans and other	$ (100)		(100)
Repurchases of common stock (Note 12) (in shares)	(3,600)	(3,624)
Repurchases of common stock (Note 12)	$ (100)		(5)	(95)
Cash dividends	(1,037)			(1,037)
Stock-based compensation expense	438		438
Balance (in shares) at Oct. 31, 2023		988,782
Balance at the end of period at Oct. 31, 2023	(1,069)	$ 10	1,505	(2,361)	(223)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	2,775			2,775
Other comprehensive loss, net of taxes	(211)				(211)
Comprehensive income	2,564
Issuance of common stock in connection with employee stock plans and other (in shares)		13,063
Issuance of common stock in connection with employee stock plans and other	$ (74)		(74)
Repurchases of common stock (Note 12) (in shares)	(62,700)	(62,856)
Repurchases of common stock (Note 12)	$ (2,126)	$ (1)	(110)	(2,015)
Cash dividends	(1,075)			(1,075)
Stock-based compensation expense	452		452
Other	$ 5		5
Balance (in shares) at Oct. 31, 2024	939,000	938,989
Balance at the end of period at Oct. 31, 2024	$ (1,323)	$ 9	1,778	(2,676)	(434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	2,529			2,529
Other comprehensive loss, net of taxes	(23)				(23)
Comprehensive income	2,506
Issuance of common stock in connection with employee stock plans and other (in shares)		11,783
Issuance of common stock in connection with employee stock plans and other	$ (109)		(109)
Repurchases of common stock (Note 12) (in shares)	(29,600)	(29,623)
Repurchases of common stock (Note 12)	$ (853)		(62)	(791)
Cash dividends	(1,088)			(1,088)
Stock-based compensation expense	522		522
Other	$ (1)			(1)
Balance (in shares) at Oct. 31, 2025	921,000	921,149
Balance at the end of period at Oct. 31, 2025	$ (346)	$ 9	$ 2,129	$ (2,027)	$ (457)